More than a thousand words.

Interview of Dr. Cacabelos on TVG

Last Saturday, 8th May 2021, Dr. Cacabelos was interviewed in the TVG TV programme A Revista FDS. For all those who are interested, clicking hereyou can access the interview in this program.

Euroespes Group

The EuroEspes Group, made up of the EuroEspes Biomedical Research Centre, EuroEspes Biotechnology and EuroEspes Publishing, is an international benchmark in research, implementation and dissemination of the most innovative advances in Genomic and Personalised Medicine, as well as in Health Biotechnology and the development of Therapeutic Bioproducts.

EuroEspes Medical Centre

The EuroEspes Biomedical Research Centre, through the Institute of Medical Sciences and Genomic Medicine, offers cutting-edge medical care aimed at early diagnosis, disease prevention and individualised treatment based on knowledge of the Human Genome.

World Alzheimer's Day

On World Alzheimer's Day, Dr. Cacabelos wanted to emphasise the need to increase prevention and personalisation of the treatment of this disease using the knowledge and tools offered by Genomic Medicine.

Attention Deficit Hyperactivity Disorder (ADHD)

Statements by Dr. Ramón Cacabelos about one of the most prevalent psychiatric diseases in children: Attention Deficit Hyperactivity Disorder. The book "Attention Deficit Hyperactivity Disorder: Epidemiology, Treatment and Prevention" has recently been published, in which Dr. Cacabelos has participated with the most extensive chapter of the work dedicated to the genomics and pharmacogenomics of the disorder.

We look after executives

Protocol aimed at those groups of people who, due to the performance of their jobs, are subjected to an accelerated pace of life. The genetics of each individual and the daily events related to their business activity, such as risky decisions, nutritional imbalance, work conflicts or family problems, sometimes become triggers for many of their health problems.

Neuropsychological assessment

Neuropsychological assessment, as a sub-area of Clinical Neuropsychology, has as its main objective the determination of a patient's cognitive, functional and affective-behavioural functioning profile through the use of standardised instruments and specialised protocols. The integration and meticulous interpretation of the information gathered is of valuable use in the diagnosis, prognosis and treatment of a wide range of pathologies derived from the involvement of the Central Nervous System.

EuroPharmaGenics Platform

Interview with Dr. Cacabelos on the Discovery DSalud TV channel in which he explains the development and operation of the new pharmacogenomics platform